Fabry Disease

Moss-aGal

is our lead product which exhibits optimized glycosylation patterns and superior features …

Learn more

Gaucher's Disease

Moss-GBA

is our proprietary drug candidate for enzyme replacement therapy of patients suffering from Gaucher's disease …

Learn more

Products & Services

Pipeline

Based on our innovative BryoTechnology platform, we have established a pipeline of proprietary clinical candidates …

Learn more

News & Events

Dechema's meeting: Scale-up And Scale-down Of Bioprocesses

Hamburg, Germany, Ramada Hotel HH-Bergedorf

May 11 – May 13, 2015